NDLI: The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study

Content Provider	Springer Nature : BioMed Central
Author	Omrani, Ali S. Almaslamani, Muna A. Daghfal, Joanne Alattar, Rand A. Elgara, Mohamed Shaar, Shahd H. Ibrahim, Tawheeda B. H. Zaqout, Ahmed Bakdach, Dana Akkari, Abdelrauof M. Baiou, Anas Alhariri, Bassem Elajez, Reem Husain, Ahmed A. M. Badawi, Mohamed N. Abid, Fatma Ben Abu Jarir, Sulieman H. Abdalla, Shiema Kaleeckal, Anvar Choda, Kris Chinta, Venkateswara R. Sherbash, Mohamed A. Al-Ismail, Khalil Abukhattab, Mohammed Ait Hssain, Ali Coyle, Peter V. Bertollini, Roberto Frenneaux, Michael P. Alkhal, Abdullatif Al-Kuwari, Hanan M.
Abstract	Background There are limited data on Coronavirus Disease 2019 (COVID-19) outcomes at a national level, and none after 60 days of follow up. The aim of this study was to describe national, 60-day all-cause mortality associated with COVID-19, and to identify risk factors associated with admission to an intensive care unit (ICU). Methods This was a retrospective cohort study including the first consecutive 5000 patients with COVID-19 in Qatar who completed 60 days of follow up by June 17, 2020. The primary outcome was all-cause mortality at 60 days after COVID-19 diagnosis. In addition, we explored risk factors for admission to ICU. Results Included patients were diagnosed with COVID-19 between February 28 and April 17, 2020. The majority (4436, 88.7%) were males and the median age was 35 years [interquartile range (IQR) 28–43]. By 60 days after COVID-19 diagnosis, 14 patients (0.28%) had died, 10 (0.2%) were still in hospital, and two (0.04%) were still in ICU. Fatal COVID-19 cases had a median age of 59.5 years (IQR 55.8–68), and were mostly males (13, 92.9%). All included pregnant women (26, 0.5%), children (131, 2.6%), and healthcare workers (135, 2.7%) were alive and not hospitalized at the end of follow up. A total of 1424 patients (28.5%) required hospitalization, out of which 108 (7.6%) were admitted to ICU. Most frequent co-morbidities in hospitalized adults were diabetes (23.2%), and hypertension (20.7%). Multivariable logistic regression showed that older age [adjusted odds ratio (aOR) 1.041, 95% confidence interval (CI) 1.022–1.061 per year increase; P < 0.001], male sex (aOR 4.375, 95% CI 1.964–9.744; P < 0.001), diabetes (aOR 1.698, 95% CI 1.050–2.746; P 0.031), chronic kidney disease (aOR 3.590, 95% CI 1.596–8.079, P 0.002), and higher BMI (aOR 1.067, 95% CI 1.027–1.108 per unit increase; P 0.001), were all independently associated with increased risk of ICU admission. Conclusions In a relatively younger national cohort with a low co-morbidity burden, COVID-19 was associated with low all-cause mortality. Independent risk factors for ICU admission included older age, male sex, higher BMI, and co-existing diabetes or chronic kidney disease.
Related Links	https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-020-05511-8.pdf
Ending Page	11
Page Count	11
Starting Page	1
File Format	HTM / HTML
ISSN	14712334
DOI	10.1186/s12879-020-05511-8
Journal	BMC Infectious Diseases
Issue Number	1
Volume Number	20
Language	English
Publisher	BioMed Central
Publisher Date	2020-10-19
Access Restriction	Open
Subject Keyword	Infectious Diseases Parasitology Medical Microbiology Tropical Medicine Internal Medicine Coronavirus COVID-19 SARS-CoV-2 Mortality Qatar
Content Type	Text
Resource Type	Article
Subject	Infectious Diseases
Journal Impact Factor	3.4/2023
5-Year Journal Impact Factor	3.3/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Effects of early corticosteroid use in patients with severe coronavirus disease 2019

Positive results for patients with COVID-19 discharged form hospital in Chongqing, China

Long-term immune responses in patients with confirmed novel coronavirus disease-2019: a 9-month prospective cohort study in Shanghai, China

Coronavirus disease (COVID-19) pandemic: an overview of systematic reviews

EuCARE-hospitalised study protocol: a cohort study of patients hospitalised with COVID-19 in the EuCARE project

Paxlovid reduces the 28-day mortality of patients with COVID-19: a retrospective cohort study

The coronavirus diseases 2019 (COVID-19) pneumonia with spontaneous pneumothorax: a case report

The potential role of serum angiotensin-converting enzyme in coronavirus disease 2019

RT-qPCR half-reaction optimization for the detection of SARS-CoV-2

The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study

Similar Documents

Effects of early corticosteroid use in patients with severe coronavirus disease 2019

Positive results for patients with COVID-19 discharged form hospital in Chongqing, China

Long-term immune responses in patients with confirmed novel coronavirus disease-2019: a 9-month prospective cohort study in Shanghai, China

Coronavirus disease (COVID-19) pandemic: an overview of systematic reviews

EuCARE-hospitalised study protocol: a cohort study of patients hospitalised with COVID-19 in the EuCARE project

Paxlovid reduces the 28-day mortality of patients with COVID-19: a retrospective cohort study

The coronavirus diseases 2019 (COVID-19) pneumonia with spontaneous pneumothorax: a case report

The potential role of serum angiotensin-converting enzyme in coronavirus disease 2019

RT-qPCR half-reaction optimization for the detection of SARS-CoV-2

The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study